First autologous stem cell transplant successfully performed on 32-month-old child
The Children’s Hospital 2 in Ho Chi Minh City has successfully performed an autologous stem cell transplant on the smallest patient so far - a 32-month-old girl suffering from severe neuroblastoma (NB).
Dr Trinh Huu Tung (standing), Director of the Children’s Hospital 2 (Photo: VNA)
HCM City (VNA) - The Children’sHospital 2 in Ho Chi Minh City has successfully performed an autologous stemcell transplant on the smallest patient so far - a 32-month-old girl sufferingfrom severe neuroblastoma (NB).
According to Dr Trinh Huu Tung, Director of thehospital, the patient, from the Central Highlands province of Dak Lak, washospitalised last June with severe abdominalpain and malnutrition. Without a hematopoietic stem-cell transplant, thesurvival rate was only 12 percent.
The patient received an autologous stem cell transplanton December 20. Sixteen days after the surgery, she was discharged from thehospital in good health. At her first post-surgery examination, she showed goodsigns of recovery.
The 32-month-old girl at her first post-surgery examination (Photo: VNA)
This is the first time the hospital has performed sucha surgery on a small child with serious health conditions, Tung said, addingthat each year the hospital treats about 40 children suffering from NB.
The hospital has built a stem cell transplant centre whichbecame operational last December, he said./.
For the first time in history, Vietnamese doctors have successfully carried out two bowel transplants from live donors, considered one of the most difficult organ transplant techniques.
The Hanoi-based Military Central Hospital 108 has become the first medical facility in Vietnam and Southeast Asia to successfully perform a double forearm transplant.
Vietnam has marked a new imprint in the world medical map with the successful performance of the world’s first limb transplant from a live donor by doctors of the Central Military Hospital 108.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.